ATE234082T1 - Adenosin enthaltendes arzneimittel - Google Patents

Adenosin enthaltendes arzneimittel

Info

Publication number
ATE234082T1
ATE234082T1 AT98932488T AT98932488T ATE234082T1 AT E234082 T1 ATE234082 T1 AT E234082T1 AT 98932488 T AT98932488 T AT 98932488T AT 98932488 T AT98932488 T AT 98932488T AT E234082 T1 ATE234082 T1 AT E234082T1
Authority
AT
Austria
Prior art keywords
product containing
medicinal product
containing adenosine
adenosine
weakened
Prior art date
Application number
AT98932488T
Other languages
English (en)
Inventor
Ilan Cohn
Pnina Fishman
Original Assignee
Can Fite Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Can Fite Biopharma Ltd filed Critical Can Fite Biopharma Ltd
Application granted granted Critical
Publication of ATE234082T1 publication Critical patent/ATE234082T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT98932488T 1997-07-10 1998-07-10 Adenosin enthaltendes arzneimittel ATE234082T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12127297A IL121272A (en) 1997-07-10 1997-07-10 Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
PCT/IL1998/000324 WO1999002143A2 (en) 1997-07-10 1998-07-10 Medicament comprising adenosine

Publications (1)

Publication Number Publication Date
ATE234082T1 true ATE234082T1 (de) 2003-03-15

Family

ID=11070366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98932488T ATE234082T1 (de) 1997-07-10 1998-07-10 Adenosin enthaltendes arzneimittel

Country Status (8)

Country Link
US (1) US6911435B1 (de)
EP (1) EP0994702B1 (de)
JP (1) JP2001509479A (de)
AT (1) ATE234082T1 (de)
AU (1) AU8239298A (de)
DE (1) DE69812100T2 (de)
IL (1) IL121272A (de)
WO (1) WO1999002143A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127947A0 (en) 1999-01-07 1999-11-30 Can Fite Technologies Ltd Pharmaceutical use of adenosine agonists
US6790839B2 (en) 1999-01-07 2004-09-14 Can-Fite Biopharma Ltd. Pharmaceutical administration of adenosine agonists
IL131096A (en) 1999-07-26 2004-09-27 Can Fite Technologies Ltd Method for preparing a composition derived from muscle tissue
IL133680A0 (en) * 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
EP1205754B1 (de) * 2000-11-07 2005-07-13 Advanced Gene Technology, Corp. Verfahren zum Screenen von Pflanzenextrakten nach Wirkstoffen
US20040204481A1 (en) * 2001-04-12 2004-10-14 Pnina Fishman Activation of natural killer cells by adenosine A3 receptor agonists
US7414036B2 (en) 2002-01-25 2008-08-19 Muscagen Limited Compounds useful as A3 adenosine receptor agonists
US20060134779A1 (en) * 2004-03-10 2006-06-22 Banes Albert J Modulation of cell intrinsic strain to control cell modulus, matrix synthesis, secretion, organization, material properties and remodeling of tissue engineered constructs
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
WO2008154532A1 (en) * 2007-06-11 2008-12-18 California Pacific Medical Center Method and kit for dynamic gene expression monitoring
CA2695950C (en) * 2007-08-16 2016-06-07 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Compositions containing nucleosides and manganese and their uses
CN102172359A (zh) * 2011-03-02 2011-09-07 张始状 腺苷与核苷组合在制备治疗肿瘤药物中的应用
TR201809040T4 (tr) * 2011-03-21 2018-07-23 Vivolux Ab Solid tümörlerin tedavisi.
MX369470B (es) 2012-09-21 2019-11-08 Vivolux Ab Medios y método para el tratamiento de tumores sólidos.
US10369166B2 (en) * 2014-09-30 2019-08-06 Susan Eve VECHT-LIFSHITZ Pharmaceutical compositions for treating ebola virus disease

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB797237A (en) * 1955-07-26 1958-06-25 Sterling Drug Inc Composition for reducing period of anesthesia
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4673563A (en) * 1980-10-14 1987-06-16 The University Of Virginia Alumni Patents Foundation Adenosine in the treatment of supraventricular tachycardia
AU8379182A (en) * 1981-06-04 1982-12-09 Procter & Gamble Company, The Composition of salicylates and purine derivatives
US5231086A (en) * 1985-09-24 1993-07-27 Item Development Aktiebolag Continuous administration adenosine to increase myocardial blood flow
US5104859A (en) * 1985-09-24 1992-04-14 Solimedco Aktiebolag Continuous administration of adenosine to reduce pulmonary vascular resistance
US5449665A (en) * 1985-09-24 1995-09-12 Item Development Aktiebolag Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
US5145771A (en) * 1990-04-12 1992-09-08 The University Of North Carolina At Chapel Hill Rinse solution for organs and tissues
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
US5882927A (en) * 1992-03-16 1999-03-16 Isis Pharmaceuticals, Inc. Oligonucleotide inhibition of protein kinase C
IL108522A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Pharmaceutical compositions containing adenosine deaminase inhibitors, for preventing or treating thrombosis ischemia and inflammatory conditions, especially sepsis
SE9301324D0 (sv) * 1993-04-21 1993-04-21 Item Development Ab New method of treatment
US5686114A (en) * 1995-06-02 1997-11-11 University Of Iowa Research Foundation Uses of inorganic pyrophosphates
NZ331434A (en) 1998-08-19 2001-02-23 Sullivan & Haddon Group Ltd Elongate building materials such as metal beams, bars and tubes, and process for making them
IL127947A0 (en) * 1999-01-07 1999-11-30 Can Fite Technologies Ltd Pharmaceutical use of adenosine agonists
US20020037871A1 (en) * 1999-01-07 2002-03-28 Pnina Fishman Pharmaceutical use of adenosine agonists
US6790839B2 (en) * 1999-01-07 2004-09-14 Can-Fite Biopharma Ltd. Pharmaceutical administration of adenosine agonists
IL133680A0 (en) * 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
US7732484B2 (en) * 2000-08-01 2010-06-08 University Of Virginia Patent Foundation Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis

Also Published As

Publication number Publication date
DE69812100D1 (de) 2003-04-17
WO1999002143A3 (en) 1999-08-12
AU8239298A (en) 1999-02-08
IL121272A (en) 2000-06-01
US6911435B1 (en) 2005-06-28
WO1999002143A2 (en) 1999-01-21
JP2001509479A (ja) 2001-07-24
EP0994702A2 (de) 2000-04-26
IL121272A0 (en) 1998-01-04
DE69812100T2 (de) 2003-07-10
EP0994702B1 (de) 2003-03-12

Similar Documents

Publication Publication Date Title
ATE234082T1 (de) Adenosin enthaltendes arzneimittel
DE60038104D1 (de) Arzneimittelzubereitungen für die behandlung von alpha-galactosidase a-mangel
EP0230575A3 (de) Arzneimittel mit Antitumorwirkung das Hexadecylphosphocholin enthält
AU6253886A (en) Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
BR9206631A (pt) Sistema de maior penetração na pele para melhor administração tópica de medicamentos
FI881579A7 (fi) Syövänvastainen terapia ja sytotoksiset lääkkeet sen suorittamiseksi.
ES2053198T3 (es) Sistema de suministro de un farmaco de glucano y adyuvante.
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
IS2537B (is) Lyfjablanda til inngjafar um húð
NO20001087D0 (no) Medikament for forlengelse av muskelfunksjon eller behandling av muskelforstyrrelser eller -sykdommer
DK0855916T3 (da) Farmaceutisk præparat indeholdende en Activin-stimulator
ES2144054T3 (es) Complejos de tri(platino).
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
DK0825865T3 (da) Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat
NO892764L (no) Medikamentell administreringsform for droevtyggere.
PL326629A1 (en) Application of flupyrtin in prophylaxy and therapy of deseases associated with damaged hematopoietic cellular system
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
SE9000207D0 (sv) Laekemedel samt anvaendningen av detsamma
IT8448710A1 (it) Riduzione degli effetti tossici causati da farmaci antrachinonici
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
DE50005282D1 (de) Medikament sowie aufeinander abgestimmte kombination von medikamenten
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
FR2694292B1 (fr) Dérivés de benzimidazole-2-thione-, leur préparation et leur application en tant que médicament.
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties